Ascites, Malignant
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites (NCT06759064) | Qilu Hospital of Shandong University | 2024-09-12 |
| PMCF Study of the CE-marked Drainova® ArgentiC Catheter (NCT06436807) | ewimed GmbH | 2024-06-26 |
| QOL and Sarcopenia in Patients With Ascites (NCT05726747) | Abramson Cancer Center at Penn Medicine | 2023-05-23 |
| Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites (NCT06046963) | Zhejiang Cancer Hospital | 2023-03-01 |
| Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (NCT05461430) | Travera Inc | 2022-07-15 |
| Quality of Life of Patients Who Have Rocket Indwelling Pleural Catheter Drainage or Repeated Large Volume Paracentesis (NCT03550690) | Gloucestershire Hospitals NHS Foundation Trust | 2018-09-01 |
Track Ascites, Malignant automatically
Every clearance here is in the API, with alerts when new ones post.